Cipla Limited has agreed to acquire additional stake worth INR 25.90 crore in digital tech company GoApptiv Private Limited. Post completion of the deal, Cipla’s total stake in GoApptiv will increase to 22.02% on a fully diluted basis.
The investment will be made in equity shares and Compulsorily Convertible Preference Shares. The deal is expected to be completed within 30 days or as mutually agreed upon by the parties, subject to necessary closing conditions.
Cipla’s earlier investment in GoApptiv in June 2020 proved successful in expanding the company’s channel reach across lower-tier towns in India. Umang Vohra, MD, and Global CEO of Cipla Limited, emphasized that the investment would strengthen their partnership with GoApptiv, enabling wider patient reach with affordable and quality drugs.
GoApptiv is a digital tech company offering digital solutions to pharmaceutical companies for increasing patient reach. The company provides end-to-end business solutions, including distribution, digital marketing, patient support, healthcare data analytics, and channel engagement for healthcare companies.
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.